Ken Bloom

Ken Bloom is a seasoned expert in pathology and genomic services, currently serving as the Head of Pathology at Nucleai since June 2022. Prior to this role, Ken Bloom held the position of Chief Medical Officer of Advanced Pathology and Genomic Services at Invicro and Ambry Genetics from June 2018 to April 2022. Ken Bloom's experience includes consulting for Human Longevity, Inc. in early 2018 and leading oncology and immunotherapy efforts at the same organization from February 2016 to December 2017. As President and CEO of Clarient Pathology Services from August 2004 to February 2016, Ken Bloom oversaw pathology services for associated diagnostic companies. Additional roles include serving as Chief Medical Officer at Clarient, where responsibilities included managing medical affairs and R&D, and Medical Director at Clarient Diagnostic Services, where Ken Bloom was instrumental in establishing the lab's operations and developing numerous laboratory tests. Ken Bloom's career also includes a role as Medical Director at US Labs from 2002 to 2004. Ken Bloom obtained a Doctor of Medicine degree from Rush Medical College and a Bachelor of Arts in Chemistry from Grinnell College.